查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生物功能晶片市场（OOC）：预测（2023-2028）
市场调查报告书
商品编码
1410141

全球生物功能晶片市场（OOC）：预测（2023-2028）

Organs-on-Chip Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计2021年全球生物功能晶片（OOC）市场规模将达到74,827,000美元，预测期内复合年增长率为26.72%，2028年将达到392,621,000美元。

有机功能晶片（OOC）是一种含有活细胞的功能微晶片，具有模拟整个器官或器官系统的活动、动态和生理反应的潜力，是人造器官的一种。每个生物功能晶片大约有硬币大小，包含微流体通道，排列有活的人体细胞，并与人体人工脉管系统连接。生物功能晶片（OOC）市场的推动因素包括对有效药物研发发现和研发的需求不断增长、研究中对动物模型替代品的需求不断增长、药物重复利用方法的增加以及政府研究法规和津贴。因此，我们持续成长稳定。此外，生物功能晶片（OOC）模型开发的研究和资金的增加、个人化医疗的需求以及疾病建模、患者分层和表型筛检等晶片的广泛应用也是推动市场成长的因素。

然而，晶片的高成本和模仿人体器官的复杂性为市场的持续成长带来了挑战。因此，领先的公司和研究人员正在签订协议和成立合资企业，以增加创新新产品研究和开发的资金。

该研究报告根据类型、应用、产品、最终用户和区域等各个细分市场对市场进行了研究。首先简要介绍了市场概况，详细介绍了主要驱动因素和挑战。接下来我们利用波特五力模型对生物功能晶片产业进行全面分析。随后，价值链分析确定了属于不同流程、对不同领域做出贡献的公司。

它还提供了有关影响生物功能晶片市场的市场开拓、趋势、行业政策和法规的详细资讯。此外，本研究分析了生物功能晶片产业的整体法规结构，旨在让相关人员更了解影响整体市场环境的关键因素。

《全球生物功能晶片市场 (OOC)：预测（2023-2028 年）》是一份综合性的新报告。向管理层和有兴趣的相关人员提供关键的市场讯息，并提供重要的市场资讯。它还分析了主要市场参与者的竞争形势和详细策略，并将其绘製在四象限供应商矩阵中：领导者、追随者、挑战者和利基市场。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
  • 产业价值链分析

第五章生物功能晶片（OOC）市场：按类型

  • 介绍
  • 肝
  • 肾
  • 肺
  • 心
  • 其他的

第六章生物功能晶片（OOC）市场：依应用

  • 介绍
  • 药物研发
  • 毒性试验
  • 生理模型

第七章生物功能晶片（OOC）市场：透过提供

  • 介绍
  • 产品
  • 服务

第八章生物功能晶片（OOC）市场：依最终用户分类

  • 介绍
  • 研究机构
  • 製药公司

第九章生物功能晶片（OOC）市场：按地区

  • 介绍
  • 美洲
    • 美国
    • 其他的
  • 欧洲/中东/非洲
    • 德国
    • 英国
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 其他的

第十章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 併购/协议/合作
  • 供应商竞争力矩阵

第十一章 公司简介

  • AxoSim Inc.
  • BiomimX SRL
  • CN Bio
  • Emulate Inc.
  • InSphero AG
  • MIMETAS BV
  • Nortis Inc.
  • TissUse GmbH.
简介目录
Product Code: KSI061612935

The organs-on-chip market was valued at US$74.827 million in 2021 and is projected to expand at a CAGR of 26.72% over the forecast period to reach US$392.621 million by 2028.

An organ-on-a-chip (OOC) is a functional microchip housing living cells that have the possibility of simulating the activities, mechanics, and physiological response of entire organs and organ systems, a type of artificial organ. Each organ-on-chip is about the size of a coin and contains microfluidic channels, which are lined by living human cells and interfaced with a human artificial vasculature. The organs-on-chip market has been on a steady growth pace because of the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government regulations and grants for the research. The increasing research and funding for the development of the organ-on-chip model, along with the demand for personalized medication and vast application of the chip, such as disease modelling, patient stratification, and phenotypic screening, has also led to market growth.

However, the high cost of the chip and the complexities of mimicking human organs pose a challenge for the growth of the market to continue. Therefore, the key players and researchers are doing agreements and joint ventures and increasing the fund for doing research and developing innovative and new products.

This research study examines the organs-on-chip market based on various segments: type, application, offerings, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model comprehensively analyzes the organs-on-chip industry. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the organs-on-chip market. Moreover, the research study analyzes the overall regulatory framework of the organs-on-chip sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Organs-on-chip Market - Forecasts from 2023 to 2028 is a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the organs-on-chip market report is as below:

  • Organs-on-chip market data tables and charts
  • Market outlook with sections on drivers, restraints, Porter's, and industry value chain analysis
  • Market assessment by type into liver, kidney, lung, heart, and others.
  • Detailed market trends, analysis, and graphical representation by application into drug discovery, toxicity testing, and physiological model and by offering into products and services.
  • In-depth analysis of the organs-on-chip market by end-user into research institutes and pharmaceutical companies.
  • A 360o view of the demand for organs-on-chip solutions/services across different geographies (Americas, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Different segments covered under the organs-on-chip market report are as below:

By Type

  • Liver
  • Kidney
  • Lung
  • Heart
  • Others

By Application

  • Drug Discovery
  • Toxicity Testing
  • Physiological Model

By Offering

  • Products
  • Services

By End-User

  • Research Institute
  • Pharmaceutical Companies

By Geography

  • Americas
  • USA
  • Others
  • Europe, Middle East, and Africa
  • Germany
  • United Kingdom
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. ORGANS ON CHIP MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Liver
  • 5.3. Kidney
  • 5.4. Lung
  • 5.5. Heart
  • 5.6. Others

6. ORGANS ON CHIP MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Drug Discovery
  • 6.3. Toxicity Testing
  • 6.4. Physiological Model

7. ORGANS ON CHIP MARKET, BY OFFERING

  • 7.1. Introduction
  • 7.2. Products
  • 7.3. Services

8. ORGANS ON CHIP MARKET, BY END-USER

  • 8.1. Introduction
  • 8.3. Research Institutes
  • 8.4. Pharmaceutical Companies

9. ORGANS ON CHIP MARKET, BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. Americas
    • 9.2.1. USA
    • 9.2.2. Others
  • 9.3. Europe, Middle East and Africa
    • 9.3.1. Germany
    • 9.3.2. United Kingdom
    • 9.3.3. Others
  • 9.4. Asia Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
    • 9.4.4. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. AxoSim Inc.
  • 11.2. BiomimX SRL
  • 11.3. CN Bio
  • 11.4. Emulate Inc.
  • 11.5. InSphero AG
  • 11.6. MIMETAS BV
  • 11.7. Nortis Inc.
  • 11.8. TissUse GmbH.